Systematic review for the development of a pharmaceutical and medical products prioritization framework
Frutos Pérez-Surio, Alberto (Universidad de Zaragoza) ; Gimeno-Gracia, Mercedes ; Alcácera López, María Aránzazu ; Sagredo Samanes, María Asunción ; Pardo Jario, María del Puerto ; Salvador Gómez, María del Tránsito
Resumen: Objective
To identify and analyze the criteria, approaches, and conceptual frameworks, used for national/international priority setting.
Data sources
We performed a search of the main biomedical databases (Medline/PubMed, Embase, Centre for Reviews and Dissemination, and Cochrane), and we reviewed assessment agency websites, among other sources.
Study design
An systematic review of the literature was carried out.
Data collection
Eligibility criteria for inclusion were based on set of predefined criteria. Systematic reviews and/or qualitative studies (interviews, surveys, expert consensus, etc) that aimed to identify prioritization criteria or develop general operational frameworks for the selection of health priorities were included. A critical analysis is made of all the aspects that may be useful for any public body that intends to establish priorities in health.
Principal findings
We found that there are no standardized criteria for priority setting, although common trends have been identified regarding key elements. Eight key domains were identified: 1) need for intervention; 2) health outcomes; 3) type of benefit of the intervention; 4) economic consequences; 5) existing knowledge on the intervention/quality and uncertainties of the regarding evidence; 6) implementation and complexity of the intervention/feasibility; 7) justice and ethics; and 8) overall context.
Conclusions
Our review provides a thorough analysis of the relevant issues and offers key recommendations regarding considerations for developing a national prioritization framework. Findings are envisioned to be useful for different public organizations that are aiming to establish healthcare priorities.
Idioma: Inglés
DOI: 10.1186/s40545-019-0181-2
Año: 2019
Publicado en: Journal of Pharmaceutical Policy and Practice 12, 21 (2019), 1-7
ISSN: 2052-3211
Factor impacto SCIMAGO: 0.644 - Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1) - Health Policy (Q2)
Tipo y forma: Article (Published version)
Área (Departamento): Área Medic.Prevent.Salud Públ. (Dpto. Microb.Med.Pr.,Sal.Públ.)
Exportado de SIDERAL (2023-09-13-10:44:57)
Visitas y descargas
To identify and analyze the criteria, approaches, and conceptual frameworks, used for national/international priority setting.
Data sources
We performed a search of the main biomedical databases (Medline/PubMed, Embase, Centre for Reviews and Dissemination, and Cochrane), and we reviewed assessment agency websites, among other sources.
Study design
An systematic review of the literature was carried out.
Data collection
Eligibility criteria for inclusion were based on set of predefined criteria. Systematic reviews and/or qualitative studies (interviews, surveys, expert consensus, etc) that aimed to identify prioritization criteria or develop general operational frameworks for the selection of health priorities were included. A critical analysis is made of all the aspects that may be useful for any public body that intends to establish priorities in health.
Principal findings
We found that there are no standardized criteria for priority setting, although common trends have been identified regarding key elements. Eight key domains were identified: 1) need for intervention; 2) health outcomes; 3) type of benefit of the intervention; 4) economic consequences; 5) existing knowledge on the intervention/quality and uncertainties of the regarding evidence; 6) implementation and complexity of the intervention/feasibility; 7) justice and ethics; and 8) overall context.
Conclusions
Our review provides a thorough analysis of the relevant issues and offers key recommendations regarding considerations for developing a national prioritization framework. Findings are envisioned to be useful for different public organizations that are aiming to establish healthcare priorities.
Idioma: Inglés
DOI: 10.1186/s40545-019-0181-2
Año: 2019
Publicado en: Journal of Pharmaceutical Policy and Practice 12, 21 (2019), 1-7
ISSN: 2052-3211
Factor impacto SCIMAGO: 0.644 - Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1) - Health Policy (Q2)
Tipo y forma: Article (Published version)
Área (Departamento): Área Medic.Prevent.Salud Públ. (Dpto. Microb.Med.Pr.,Sal.Públ.)
Exportado de SIDERAL (2023-09-13-10:44:57)
Permalink:
Visitas y descargas
Este artículo se encuentra en las siguientes colecciones:
articulos > articulos-por-area > medicina_preventiva_y_salud_publica
Notice créée le 2019-08-28, modifiée le 2023-09-14